본문 바로가기

Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q2Scopus Q2KCI Q3
저널
KOREAN JOURNAL OF INTERNAL MEDICINE39(3) · pp.501 · 2024
피인용
Web of Science 5Scopus 5KCI 2
FWCI (Scopus)
0.67
JCR IF
JCR 2023 2.2
ISSN
1226-3303

저자

  1. Yhim, Ho-Young제1저자Jeonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Med Sch,Dept Internal Med,Jeonbuk Natl Univ Hosp, Jeonju, South Korea
  2. Park, YongKorea Univ, Coll Med, Anam Hosp, Dept Internal Med, Seoul, South Korea
  3. Kim, Jeong-ACatholic Univ Korea, St Vincent Hosp, Dept Internal Med, Suwon, Gyunggi Do, South Korea
  4. 신호진Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea
  5. Do, Young RokKeimyung Univ, Dongsan Med Ctr, Dept Internal Med, Daegu, South Korea
  6. Moon, Joon HoKyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea
  7. Kim, Min KyoungYeungnam Univ, Coll Med, Med Ctr, Dept Internal Med, Daegu, South Korea
  8. Lee, Won SikInje Univ, Busan Paik Hosp, Dept Internal Med, Pusan, South Korea
  9. Kim, Dae SikKorea Univ, Guro Hosp, Coll Med, Dept Internal Med, Seoul, South Korea
  10. Lee, Myung-WonChungnam Natl Univ, Coll Med, Dept Internal Med, Daejeon, South Korea
  11. Choi, Yoon SeokChungnam Natl Univ, Coll Med, Dept Internal Med, Daejeon, South Korea
  12. Jeong, Seong HyunAjou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea
  13. Kim, Kyoung HaJeonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Med Sch,Dept Internal Med,Jeonbuk Natl Univ Hosp, Jeonju, South Korea
  14. Kim, JinhangCatholic Univ Korea, St Vincent Hosp, Dept Internal Med, Suwon, Gyunggi Do, South Korea
  15. Lee, Chang-HoonJeonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Med Sch,Dept Internal Med,Jeonbuk Natl Univ Hosp, Jeonju, South Korea
  16. Song, Ga-YoungChonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Internal Med, Hwasun, South Korea
  17. Yang, Deok-Hwan교신저자Chonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Internal Med, Hwasun, South Korea
  18. Kwak, Jae-YongJeonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Med Sch,Dept Internal Med,Jeonbuk Natl Univ Hosp, Jeonju, South Korea

초록

Background/Aims: Optimal risk stratification based on simplified geriatric assessment to predict treatment -related toxicity and survival needs to be clarified in older patients with diffuse large B -cell lymphoma (DLBCL). Methods: This multicenter prospective cohort study enrolled newly diagnosed patients with DLBCL (>= 65 yr) between September 2015 and April 2018. A simplified geriatric assessment was performed at baseline using Activities of Daily Living (ADL), Instrumental ADL (IADL), and Charlson's Comorbidity Index (CCI). The primary endpoint was event -free survival (EFS). Results: The study included 249 patients, the median age was 74 years (range, 65-88), and 125 (50.2%) were female. In multivariable Cox analysis, ADL, IADL, CCI, and age were independent factors for EFS; an integrated geriatric score was derived and the patients stratified into three geriatric categories: fit (n = 162, 65.1%), intermediate -fit (n = 25, 10.0%), and frail (n = 62, 24.9%). The established geriatric model was significantly associated with EFS (fit vs. intermediate -fit, HR 2.61, p < 0.001; fit vs. frail, HR 4.61, p < 0.001) and outperformed each covariate alone or in combination. In 87 intermediate -fit or frail patients, the relative doxorubicin dose intensity (RDDI) >= 62.4% was significantly associated with worse EFS (HR, 2.15, 95% CI 1.30-3.53, p = 0.002). It was related with a higher incidence of grade >= 3 symptomatic non -hematologic toxicities (63.2% vs. 27.8%, p < 0.001) and earlier treatment discontinuation (34.5% vs. 8.0%, p < 0.001) in patients with RDDI >= 62.4% than in those with RDDI < 62.4%. Conclusions: This model integrating simplified geriatric assessment can risk -stratify older patients with DLBCL and identify those who are highly vulnerable to standard dose -intensity chemoimmunotherapy.

키워드

Diffuse large B-cell lymphomaSimplified geriatric assessmentPrognosisDose intensityToxicityELDERLY-PATIENTSR-CHOPRESPONSE ASSESSMENTDOSE INTENSITYSINGLE-ARMCHEMOTHERAPYPOPULATIONSURVIVALFRAILTYTOOL

식별자

Scopus EID
2-s2.0-85192680923
WoS UID
001155682100001
KCI
ART003074207